Ginger Vieira
What’s New in Dexcom’s G7 Continuous Glucose Monitor
The Dexcom G7 continuous glucose monitor (CGM) received FDA clearance in December 2022 for people with type 1, type 2,…
ATTD 2023 Research: The Impact of Diabetes Tech on Safety & Quality of Life
The 16th international ATTD (Advanced Technology and Treatments for Diabetes) conference was held in Berlin, Germany on February 22-25th. Despite…
Our Research: Your Mental Health with T1D Should Be Part of Routine Healthcare
Editor’s Note: If you are experiencing thoughts of self-harm or suicidal ideation, text the word “NAMI” to the National Alliance…
If You’ve Lived with T1D for 10, 25, 50, or 75 Years…
“Every day with type 1 diabetes is an accomplishment,” says Jeff Hitchcock who founded Children with Diabetes (CWD) after his…
Tidepool Loop FDA Clearance: Chatting with CEO Howard Look
This week’s FDA clearance of the new Tidepool Loop iPhone app means “looping” could be even simpler and likely far…
Mark Cuban’s Cost Plus Drugs Tests New Insulin Program
You may have been the lucky recipient of an invitation to Mark Cuban’s Cost Plus Drug’s “Insulin Test Program” this…
7 Things People Say About Type 1 Diabetes That Drive Us Crazy
Well, sure, we do want people to ask questions and try to learn more about type 1 diabetes. The problem…
Our Research: Young People with T1D + Other Conditions Face Higher Risk of Severe Covid-19
Our research — recently highlighted by the American Diabetes Association and Healio — continues to demonstrate that children and young…
Our Published Quality Improvement Research of 2022: Changing T1D Healthcare
The T1D Exchange Quality Improvement Collaborative (T1DX-QI) published 18 manuscripts during 2022. This variety of robust and deeply impactful work…
DiabetesMine Innovation Summit Unveils New Tech & Products for Type 1 Diabetes
There is one common goal in the diabetes healthcare industry: we want to make life with type 1 diabetes (T1D)…